Substituted cyclodextrins as chelating reagents for yperite, ethers and thioethers;Etude des cyclodextrines substituees comme agents cryptants des ethers, thioethers et de l'yperite

Annales Pharmaceutiques Francaises

Volumn 58, Issue 1, 2000, Pages 20-23

  Debouzy, J C ^a   Dabouis, V ^a   Fauvelle, F ^a   Steinbrukner S ^a   Gentilhomme, E ^a  

^a CENTRE DE RECHERCHES   (France)

Author keywords

Complex; Cyclodextrin; Mustard gas

Indexed keywords

ALPHA CYCLODEXTRIN; BETA CYCLODEXTRIN; CHELATING AGENT; ETHER; MUSTARD GAS; SULFIDE; ANTIDOTE; CYCLODEXTRIN; ETHER DERIVATIVE;

ARTICLE; BINDING AFFINITY; CHELATION; CHEMICAL MODIFICATION; COMPLEX FORMATION; DRUG BINDING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STOICHIOMETRY; CARBOHYDRATE ANALYSIS; CHEMISTRY; MOLECULAR GENETICS; NUCLEAR MAGNETIC RESONANCE;

ANTIDOTES; CARBOHYDRATE SEQUENCE; CHELATING AGENTS; CYCLODEXTRINS; ETHERS; MOLECULAR SEQUENCE DATA; MUSTARD GAS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; SULFIDES;

EID: 0033629112     PISSN: 00034509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Uekama K, Irie T. Cyclodextrins and their industrial uses. Paris: Duchene D. Ed; 1987.
2. Fromming K H, Szetjh J. Cyclodextrins in Pharmacology. Dordrecht: Kluwer Academic edn: 1997.
3. Loftsoon T, Brewster M E. Pharmaceutical applications of cyclodextrins. 1. Drug solubilisation and stabilization. J Pharm Sci 1996; 85: 1017-25.
4. Skiba M, Puisieux M, Duchene D, Wouessidjewe D. Direct imaging of modified B-cyclodextrin nanospheres by photon scanning tunnelling and scanning force microscopy. Int J Pharm 1995; 120: 1-11
5. Wenz G. Cyclodextrins as building blocks for supramolecular structures and functional units. Angew Chem 1994; 33: 803-22
6. Gominta M. Caractéristiques, intérets et utilisations des cyclodextrines, Université de Montpellier I (Pharmacie), Montpellier, 1992.
7. Rajewski R A, Stella V J. Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery. J Pharm Sci 1996; 85: 1142-69.
8. Irie T, Uekama K. Pharmaceutical applications of cyclodextrins. 3. Toxicological issues and safety evaluation. J Pharm Sci 1997; 86: 147-62.
9. Djedainai F. Étude par Résonance Magnétique Nucléaire des phénomènes d'inclusion et d'adaptation moléculaire dans les cvclodextrines naturelles et des dérivés synthétiques, Université de Paris Sud, Paris, 1991.
10. Szejth J. 1982. Cyclodextrins and their inclusion complexes. Cyclodextrins and their inclusion complexes, Budapest.
11. Job P. Étude spectrographique de la formation de complexes en solution et de leur stabilité. C R Acad Sci 1925 ; 180 : 918-30.
12. Benesi H A, Hildebrand J. H. J Am Chem Soc 1949; 71: 2703-10.
13. Fauvelle F, Jaquinod M, Pétillot Y, Forest E. Electrospray ionisation and matrix-assisted laser desorption/ionisation mass spectroscopy studies of complexation with per-3,6-anhydro-alpha-cyclodextrin. Eur Mass Spectroscopy 1996; 2: 381-4.
14. Fauvelle F. Décontamination des cations toxiques: la voie des cyclodextrines, Université Joseph Fourier, Grenoble, 1999, 230 pages.